- /
- Supported exchanges
- / MX
- / EW.MX
Edwards Lifesciences Corporation (EW MX) stock market data APIs
Edwards Lifesciences Corporation Financial Data Overview
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. It also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Edwards Lifesciences Corporation data using free add-ons & libraries
Get Edwards Lifesciences Corporation Fundamental Data
Edwards Lifesciences Corporation Fundamental data includes:
- Net Revenue: 5 685 M
- EBITDA: 1 741 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-02-10
- EPS/Forecast: 0.62
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Edwards Lifesciences Corporation News
New
BSX Posts Q4 Earnings: Should You Buy, Sell or Hold the Stock?
Boston Scientific BSX reported its fourth-quarter 2025 results on Feb. 4. Both top and bottom lines exceeded the company’s guidance ranges and topped the respective Zacks Consensus Estimate. Closed ...
Edwards Lifesciences to Present at Citi’s 2026 Unplugged Medtech and Life Sciences Access Day
IRVINE, Calif., February 13, 2026--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in Citi’s Unplugged Medtech and Life Sciences Access Day on Februa...
How Investors Are Reacting To Edwards Lifesciences (EW) 2026 Guidance After Profit Squeeze In 2025
On February 10, 2026, Edwards Lifesciences reported Q4 2025 sales of US$1,569.6 million and full‑year 2025 sales of US$6.07 billion, alongside sharply lower net income despite double‑digit revenue...
Edwards Wavers Analysts Debate Its Earnings Miss Amid Hefty TAVR Investments
Edwards Lifesciences stock wavered Wednesday, though the heart-valve replacement maker issued a bullish outlook for 2026. Continue Reading
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.